Jose Luis Labandeira
Jose Luis Labandeira-Garcia, MD, PhD - Full Professor of Human Anatomy and Embryology (USC)
Dr. Labandeira-Garcia obtained his MD and PhD degrees from the University of Santiago de Compostela (USC). He specialized in Clinical Neurology. Following his clinical training, he transitioned to an academic career at USC, focusing on teaching and research in Neuroscience. He undertook postdoctoral research in neurodegenerative diseases in the laboratory of Prof. Anders Björklund at Lund University (Sweden).
Since 1991, he has held the position of Full Professor of Human Anatomy and Embryology at USC. He currently leads a consolidated research group at CIMUS and IDIS, with a primary focus on neurodegeneration and Parkinson's disease. He serves as Principal Investigator (PI) within several national networks, including the CIBER of Neurodegenerative Diseases (CIBERNED, ISCIII), the Spanish Cell Therapy Network (TERCEL, ISCIII), and the Network for Advanced Therapies (RICORDs TERAV).
He has authored more than 200 peer-reviewed articles in leading neuroscience journals and has coordinated over 50 competitive research projects. His group has developed and licensed patents for novel therapeutic approaches in Parkinson's disease and dyskinesias.
In addition to his research activities, Dr. Labandeira-Garcia has held numerous leadership and advisory roles in scientific management, including: member of the Advisory Council for Research and Technological Development of Galicia (2006 -2010); member of the Governing Board of the Health Research Institute of Santiago (IDIS); member of the Steering Committee of CIBERNED; member of the Steering Committee of TERCEL; Coordinator of the Neuroscience Area at IDIS; and Deputy Director of CIMUS.
He has also participated in national and international scientific evaluation panels and has served as Associate Editor for high-impact, first-quartile journals indexed in the SCI.
His career combines excellence in academic leadership, innovation in translational neuroscience, and active participation in the advancement of neurotherapeutics.